<p>康宝莱的股价在今年经历了强劲的牛市突破，从三月份的低点 5 美元上涨至目前的 14 美元，市值超过 14 亿美元。那么，HLF 的股价在未来一年是否会继续强劲反弹呢？</p>
<p><strong>康宝莱股价在其稳健增长中获得动力</strong></p>
<p>康宝莱是健康和保健行业的顶尖公司，主要专注于在美国及其他国家的直销。</p>
<p>该公司的业务一直备受争议，但在过去几个月中表现相对良好，因为其产品的需求持续上升。</p>
<p>其最新的业绩显示，北美业务自 2021 年第二季度以来首次恢复增长，显示出需求的韧性。同时，网络中分销商的数量在大多数地区也有所增加。</p>
<p>关键的拉丁美洲业务继续蓬勃发展，销售额增长了 11%，达到 2.29 亿美元。其 EMEA 和亚太地区的业务分别增长了 2% 和 3%。</p>
<p>该季度收入增长了 2.7%，达到 13 亿美元，而备受关注的息税折旧摊销前利润（EBITDA）则上升至 1.63 亿美元。</p>
<p>与此同时，公司通过偿还 1.47 亿美元的未偿票据继续改善其资产负债表，并将总杠杆比率降低至 2.8 倍。</p>
<p><strong>分析师对公司的转机持乐观态度</strong></p>
<p>华尔街分析师对公司未来几周的收入增长持乐观态度。跟踪该公司的三位分析师的平均估计是，本季度收入将达到 12.5 亿美元，比去年增长 3.38%。</p>
<p>其年度收入预估 modest 增加 0.20%，达到 50 亿美元，预计明年将达到 51.2 亿美元。他们还预计今年每股收益将达到 2.15 美元，明年将达到 2.75 美元。</p>
<p>还有迹象表明，该公司已被严重低估，其前瞻市盈率已降至 7.6，远低于行业中位数 18.8 和其五年平均值 9。</p>
<p>同样，该公司的前瞻企业价值与息税折旧摊销前利润（EV-to-EBITDA）倍数为 5.43，也远低于行业中位数 10.3，且低于其历史平均水平。</p>
<p>随着投资者押注于其转型战略，康宝莱的股价也大幅上涨，该战略包括更多产品发布、数字化转型（包括 Pro2col 应用程序向近 8000 名分销商的推出）、利润优化和减债。</p>
<p><strong>康宝莱股价技术分析</strong></p>
<p>周线图显示，随着公司转型的持续，HLF 股价在过去几个月中反弹。它已经突破了 50 周和 100 周的指数移动平均线（EMA）。</p>
<p>该股也接近 23.6% 的斐波那契回撤位 18 美元。同时，它形成了一个反向头肩形态，而相对强弱指数（RSI）和随机振荡器均指向上方。</p>
<p>因此，最可能的情景是 HLF 股价将继续上涨，牛市目标为 23.6% 的回撤位 18 美元。这个价格目标比当前水平高出约 25%。</p>

康宝莱

<p>康宝莱的股价从 5 美元飙升至 14 美元，市值提升至 14 亿美元。分析师对持续的收入增长和被低估持乐观态度，预计未来市盈率为 7.6。技术分析显示进一步上涨的潜力，目标价为 18 美元，受到积极的相对强弱指数（RSI）和随机振荡器（Stochastic Oscillator）趋势的支持</p>

<p>The Herbalife stock price staged a strong bullish breakout this year, moving from a low of $5 in March to the current $14, pushing its market capitalization to over $1.4 billion. So, will the HLF share price continue its strong rebound in the coming year?</p>
<div class="lb-trans"><p>康宝莱的股价在今年经历了强劲的牛市突破，从三月份的低点 5 美元上涨至目前的 14 美元，市值超过 14 亿美元。那么，HLF 的股价在未来一年是否会继续强劲反弹呢？</p>
</div><p><strong>Herbalife stock price gains steam amid its resilient growth</strong></p>
<div class="lb-trans"><p><strong>康宝莱股价在其稳健增长中获得动力</strong></p>
</div><p>Herbalife is a top company in the health and wellness industries, focusing mostly on direct selling in the United States and other countries.</p>
<div class="lb-trans"><p>康宝莱是健康和保健行业的顶尖公司，主要专注于在美国及其他国家的直销。</p>
</div><p>The company’s business, which has always been highly controversial, has done relatively well in the past few months as demand for its products has continued rising.</p>
<div class="lb-trans"><p>该公司的业务一直备受争议，但在过去几个月中表现相对良好，因为其产品的需求持续上升。</p>
</div><p>Its most recent results showed that its North American business returned to growth for the first time since the second quarter of 2021, a sign of resilient demand. It also jumped as the number of distributors in its network jumped in most of its regions.</p>
<div class="lb-trans"><p>其最新的业绩显示，北美业务自 2021 年第二季度以来首次恢复增长，显示出需求的韧性。同时，网络中分销商的数量在大多数地区也有所增加。</p>
</div><p>The crucial Latin American business continued to thrive, with its sales rising by 11% to $229 million. Its EMEA and Asia Pacific businesses grew by 2% and 3%, respectively.</p>
<div class="lb-trans"><p>关键的拉丁美洲业务继续蓬勃发展，销售额增长了 11%，达到 2.29 亿美元。其 EMEA 和亚太地区的业务分别增长了 2% 和 3%。</p>
</div><p>The revenue rose by 2.7% in the quarter to $1.3 billion, while the closely-watched earnings before interest, tax, depreciation, and amortization rose to $163 million.</p>
<div class="lb-trans"><p>该季度收入增长了 2.7%，达到 13 亿美元，而备受关注的息税折旧摊销前利润（EBITDA）则上升至 1.63 亿美元。</p>
</div><p>Meanwhile, the company continued to improve its balance sheet by repaying the $147 million in outstanding notes and then reduced the total leverage ratio to 2.8x.</p>
<div class="lb-trans"><p>与此同时，公司通过偿还 1.47 亿美元的未偿票据继续改善其资产负债表，并将总杠杆比率降低至 2.8 倍。</p>
</div><p><strong>Analysts are optimistic about the company’s turnaround</strong></p>
<div class="lb-trans"><p><strong>分析师对公司的转机持乐观态度</strong></p>
</div><p>Wall Street analysts are optimistic that the company’s revenue growth will continue in the coming weeks. The average estimate among the three analysts tracking the company is that its revenue will be $1.25 billion this quarter, up by 3.38% from what it made last year.</p>
<div class="lb-trans"><p>华尔街分析师对公司未来几周的收入增长持乐观态度。跟踪该公司的三位分析师的平均估计是，本季度收入将达到 12.5 亿美元，比去年增长 3.38%。</p>
</div><p>Its annual revenue estimate is a modest 0.20% increase to $5 billion, followed by $5.12 billion in the coming year. They also expect that its earnings-per-share will move to $2.15 this year and $2.75 in the coming year.</p>
<div class="lb-trans"><p>其年度收入预估 modest 增加 0.20%，达到 50 亿美元，预计明年将达到 51.2 亿美元。他们还预计今年每股收益将达到 2.15 美元，明年将达到 2.75 美元。</p>
</div><p>There are also signs that the company has become highly undervalued as its forward price-to-earnings ratio has moved to 7.6, much lower than the sector median of 18.8 and its five-year average of 9.</p>
<div class="lb-trans"><p>还有迹象表明，该公司已被严重低估，其前瞻市盈率已降至 7.6，远低于行业中位数 18.8 和其五年平均值 9。</p>
</div><p>Similarly, the company’s forward EV-to-EBITDA multiple of 5.43 is also much lower than the sector median of 10.3, also much lower than its historical averages.</p>
<div class="lb-trans"><p>同样，该公司的前瞻企业价值与息税折旧摊销前利润（EV-to-EBITDA）倍数为 5.43，也远低于行业中位数 10.3，且低于其历史平均水平。</p>
</div><p>The Herbalife stock price has also jumped as investors bet on its turnaround strategy, which includes more product launches, digital transformation, including the Pro2col app rollout to nearly 8,000 distributors, margin optimization, and debt reduction.</p>
<div class="lb-trans"><p>随着投资者押注于其转型战略，康宝莱的股价也大幅上涨，该战略包括更多产品发布、数字化转型（包括 Pro2col 应用程序向近 8000 名分销商的推出）、利润优化和减债。</p>
</div><p><strong>Herbalife share price technical analysis</strong></p>
<div class="lb-trans"><p><strong>康宝莱股价技术分析</strong></p>
</div><p>The weekly chart shows that the HLF stock price has rebounded in the past few months as the company’s turnaround continued. It has already moved above the 50-week and 100-week Exponential Moving Averages (EMA).</p>
<div class="lb-trans"><p>周线图显示，随着公司转型的持续，HLF 股价在过去几个月中反弹。它已经突破了 50 周和 100 周的指数移动平均线（EMA）。</p>
</div><p>The stock is also nearing the 23.6% Fibonacci Retracement level at $18. It also formed an inverse head-and-shoulders pattern, while the Relative Strength Index (RSI) and the Stochastic Oscillator have all pointed upwards.</p>
<div class="lb-trans"><p>该股也接近 23.6% 的斐波那契回撤位 18 美元。同时，它形成了一个反向头肩形态，而相对强弱指数（RSI）和随机振荡器均指向上方。</p>
</div><p>Therefore, the most likely scenario is where the HLF stock will continue rising as bulls target the 23.6% retracement level at $18. This price target is about 25% above the current level.</p>
<div class="lb-trans"><p>因此，最可能的情景是 HLF 股价将继续上涨，牛市目标为 23.6% 的回撤位 18 美元。这个价格目标比当前水平高出约 25%。</p>
</div>

康宝莱的股票价格在 2025 年出现反弹：这种涨势会持续吗？